University Medical Center Groningen

Futó vizsgálatok

• Még nem toboroz

  Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)

  NCT07586150· Ludwig-Maximilians - University of Munich· Forrás

• Még nem toboroz

  Addition of ritonavir to ibrutinib treatment in patients with chronic leukemia and certain types of lymphoma

  2026-526101-15-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Még nem toboroz

  A Study of Brenipatide in Participants With Major Depressive Disorder

  NCT07928245· 2. fázis· Eli Lilly and Company· Forrás

• Még nem toboroz

  A Multicenter, Phase 2/3, Dose Range Finding Study to Evaluate the Efficacy and Safety of Atumelnant in Adults with ACTH-Dependent Cushing’s Syndrome (ADCS) Including an Open-Label Extension for Long-Term Assessment. (EQUILIBRIUM-ADCS)

  2025-522648-42-01· 2/3. fázis· Crinetics Pharmaceuticals Inc.· Forrás

• Toboroz

  Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  2025-523288-39-00· 2. fázis· Mediar Therapeutics Inc.· Forrás

• Toboroz

  A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease

  2026-525197-19-00· 2. fázis· Agomab Spain S.L.U.· Forrás

• Toboroz

  Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD)

  2025-525068-13-00· 2. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás

• Még nem toboroz

  Remote Monitoring and Optimization of Heart Failure Therapy

  NCT07622472· Zoll Medical Corporation· Forrás

• Még nem toboroz

  Off-line Adaptive Proton Therapy

  NCT07866547· University Medical Center Groningen· Forrás

• Toboroz

  A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)

  NCT07843940· 1/2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

  NCT07751991· 1. fázis· Charm Therapeutics· Forrás

• Toboroz

  A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  2026-526654-14-01· 3. fázis· Janssen Cilag International· Forrás

• Még nem toboroz

  A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

  NCT07719348· 1/2. fázis· Servier· Forrás

• Még nem toboroz

  A Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFREF) (CALIBRATE-HF)

  2025-525033-31-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás

• Toboroz

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)

  2025-525009-18-00· 3. fázis· Incyte Corp.· Forrás

• Toboroz

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· 3. fázis· Incyte Corporation· Forrás

• Még nem toboroz

  In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy

  NCT07653438· 2. fázis· University Medical Center Groningen· Forrás

• Még nem toboroz

  Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy

  NCT06647602· University Medical Center Groningen· Forrás

• Még nem toboroz

  Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer

  NCT07846046· Amsterdam UMC, location VUmc· Forrás

• Toboroz

  A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing in 1L R or M HNSCC

  NCT07807163· 2. fázis· Bicara Therapeutics· Forrás

• Toboroz

  A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation

  NCT07625215· 2. fázis· Bayer· Forrás

• Toboroz

  Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

  NCT07564141· 3. fázis· Genmab· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás

• Még nem toboroz

  Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy

  NCT06809946· 2. fázis· University Medical Center Groningen· Forrás

• Toboroz

  A Study of LY3971297 in Participants With Heart Failure

  NCT07547540· 1. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Tarlatamab for SCLC Brain Metastases

  NCT07402343· 2. fázis· Maastricht University Medical Center· Forrás

• Még nem toboroz

  A study investigating the safety and efficacy of academically-produced CAR T cells compared with standard treatment for patients with multiple myeloma whose disease has returned or not responded to previous treatments.

  2025-524876-43-00· 3. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)

  2023-505575-69-01· 3. fázis· Institut Gustave Roussy· Forrás

• Toboroz

  Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.

  NCT07686835· 2. fázis· Radboud University Medical Center· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  Methotrexate in paediatric and adolescent Crohn’s disease: an observational study

  2025-524129-42-00· 4. fázis· Amsterdam UMC Stichting· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  NCT07324031· AtaCor Medical, Inc.· Forrás

• Még nem toboroz

  AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation

  NCT07604727· University Medical Center Groningen· Forrás

• Toboroz

  [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

  NCT07702292· 2. fázis· Blue Earth Diagnostics· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  2025-522883-34-00· 4. fázis· Universitair Medisch Centrum Groningen· Forrás

• Toboroz

  No Guts No Glory Probiotics

  NCT07606014· 2/3. fázis· University Medical Center Groningen· Forrás

• Még nem toboroz

  Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.

  NCT07627269· University Medical Center Groningen· Forrás

• Még nem toboroz

  CANagliflozin In DIALysis Patients

  NCT07527390· 4. fázis· University Medical Center Groningen· Forrás

• Még nem toboroz

  Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients

  NCT07643727· 1. fázis· University Medical Center Groningen· Forrás

• Még nem toboroz

  HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before

  2025-524230-25-00· 2. fázis· Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting· Forrás

• Toboroz

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

  NCT07549412· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

  NCT07513376· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  The SELEQT-HF (SELEnium and CoQ10 NuTrition for Heart Failure) Study Will Evaluate the Effect of Adding Selenium/and coQ10 on Top of Standard HF Therapy in Patients With HF and Will do so Using a Pragmatic, Registry Based Randomized Controlled Trial in the Netherlands.

  NCT07234422· 3. fázis· Netherlands Heart Institute· Forrás

Showing 50 of 411.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák31 toboroz
• Gyermekkori daganatok22 toboroz
• Szívelégtelenség18 toboroz
• Gyomor- és nyelőcsőrák14 toboroz
• Máj- és epeúti rák13 toboroz
• Mielóma multiplex13 toboroz
• Vastagbélrák13 toboroz
• Fej-nyaki daganatok12 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)11 toboroz
• Crohn-betegség9 toboroz
• Méhnyakrák9 toboroz
• Petefészekrák9 toboroz
• Prosztatarák9 toboroz
• Amiloidózis8 toboroz
• Hasnyálmirigyrák8 toboroz
• Krónikus vesebetegség7 toboroz
• Melanóma7 toboroz
• Akut mieloid leukémia (AML)6 toboroz
• Magas vérnyomás6 toboroz
• Szarkóma6 toboroz
• Méhtestrák5 toboroz
• Pitvarfibrilláció5 toboroz
• Stroke (szélütés)5 toboroz
• Barrett's oesophagus4 toboroz
• Colitis ulcerosa4 toboroz
• Depresszió4 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)4 toboroz
• Koszorúér-betegség4 toboroz
• Krónikus limfoid leukémia (CLL)4 toboroz
• Aortic stenosis3 toboroz
• Brain metastases3 toboroz
• Elhízás3 toboroz
• Hodgkin-limfóma3 toboroz
• Hólyagrák3 toboroz
• Liver cirrhosis3 toboroz
• Mielodiszplasztikus szindróma (MDS)3 toboroz
• Parkinson-kór3 toboroz
• Sjögren-szindróma3 toboroz
• Skizofrénia3 toboroz
• Testicular cancer3 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Áttétes emlőrák2 toboroz
• Dilated cardiomyopathy2 toboroz
• Follikuláris limfóma2 toboroz
• Glioblasztóma2 toboroz
• Hemofília2 toboroz
• Hidradenitis suppurativa2 toboroz
• Huntington-kór2 toboroz
• Hypothyroidism2 toboroz
• Köpenysejtes limfóma2 toboroz
• Lupus (SLE)2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Mild cognitive impairment2 toboroz
• Peripheral artery disease2 toboroz
• Pikkelysömör2 toboroz
• Policisztás vesebetegség2 toboroz
• Rheumatoid arthritis2 toboroz
• Sclerosis multiplex (SM)2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Tripla negatív emlőrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Alzheimer-kór1 toboroz
• Amiotrófiás laterálszklerózis (ALS)1 toboroz
• ANCA-asszociált vasculitis1 toboroz
• Antiphospholipid syndrome1 toboroz
• Aortic aneurysm1 toboroz
• Bipoláris zavar1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Cushing's syndrome1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Dermatomyositis and polymyositis (myositis)1 toboroz
• Diabetic foot ulcer1 toboroz
• Diabetic neuropathy1 toboroz
• Endometriózis1 toboroz
• Female infertility1 toboroz
• Giant cell arteritis1 toboroz
• HIV-fertőzés1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Long COVID és ME/CFS1 toboroz
• Meningioma1 toboroz
• Multiple system atrophy1 toboroz
• Neuroblasztóma1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pajzsmirigyrák1 toboroz
• Polycystic ovary syndrome1 toboroz
• Pulmonális artériás hipertónia1 toboroz
• Ventricular tachycardia1 toboroz
• Vitiligo1 toboroz

Lezárt vizsgálatok

• Visszavonták

  A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

  NCT07084831· 3. fázis· European Group for Research In Schizophrenia· Forrás

• Még nem toboroz

  The MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.

  2025-522359-24-00· 2. fázis· University Of Leicester· Forrás

• Visszavonták

  PREcision meDICine in Treatment in CardioVascular Disease

  NCT07369141· Maastricht University Medical Center· Forrás

• Toboroz

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Fut, nem toboroz

  Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

  NCT07161037· 2. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  The Added Value of Three-dimensional Electroanatomic Mapping For Accurate Delivery Of Pulsed Field Ablation In The Pulmonary Veins Compared To Pulsed Field Ablation With Fluoroscopy And/Or Intracardiac Echocardiography Alone In The Treatment Of Atrial Fibrillation: MAP-PFA Study

  NCT07014423· University Medical Center Groningen· Forrás

• Lezárult

  SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study).

  2025-521235-37-00· 1. fázis· Fusion Pharmaceuticals Inc.· Forrás

• Toboroz

  Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  NCT06966401· 3. fázis· Neurocrine Biosciences· Forrás

• Lezárult

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· 3. fázis· Argenx· Forrás

• Lezárult

  A first-in-human study to determine the safety and tolerability of different doses of GEH200520 Injection and GEH200521 (18F) Injection and their uses in positron emission tomography imaging for patients with cancer

  2024-515218-42-00· 1. fázis· GE Healthcare Limited· Forrás

• Lezárult

  GENPAD

  NCT04619927· 4. fázis· Radboud universitair medisch centrum Stichting· Forrás

• Toboroz

  PET-imaging of Two Vartumabs in Patients With Solid Tumors

  NCT06645808· Korai 1. fázis· Var2 Pharmaceuticals· Forrás

• Lezárult

  Optical PD-L1 imaging using Quantitative Fluorescence Endoscopy in locally advanced esophageal cancer using durvalumab-680LT: a phase I multicenter feasibility and safety study

  2024-517258-85-00· 1. fázis· Universitair Medisch Centrum Groningen· Forrás

• Lezárult

  A Patient guided dose reduction strategy of tyrosine kinase inhibitors in chronic myeloid leukaemia: RODEO study

  2024-516511-24-00· 4. fázis· Stichting Radboud universitair medisch centrum· Forrás

• Lezárult

  DECISION; Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands

  2023-509898-23-00· 4. fázis· Universitair Medisch Centrum Groningen· Forrás

• Lezárult

  A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction

  2023-508736-62-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  Iptacopan in Patients With ANCA Associated Vasculitis

  NCT06388941· 2. fázis· Novartis Pharmaceuticals· Forrás

• Leállították

  Bariatric Surgery Evaluation and Assessment of Treatment Efficacy - Intervention Trial

  NCT06065124· University Medical Center Groningen· Forrás

• Lezárult

  Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction

  2023-506210-40-00· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.

  NCT06359002· 1. fázis· Byondis B.V.· Forrás

• Lezárult

  EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)

  NCT06362668· Reprieve Cardiovascular, Inc· Forrás

• Lezárult

  Evaluation of a Self-compassion App in People With Cancer: Feasibility, Acceptability and Changes in Well-being

  NCT07415629· University Medical Center Groningen· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

  NCT06238817· 3. fázis· Incyte Corporation· Forrás

• Visszavonták

  JDQ443 for KRAS G12C NSCLC Brain Metastases

  NCT05999357· 2. fázis· Maastricht University Medical Center· Forrás

• Lezárult

  EHRA-PATHS: Clinical and Health Economic Evaluation of New Care Pathways

  NCT05773768· University Medical Center Groningen· Forrás

• Lezárult

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· 2. fázis· Novartis Pharma AG· Forrás

• Lezárult

  A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma

  2023-504304-29-00· 1. fázis· F. Hoffmann-La Roche AG· Forrás

• Lezárult

  Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)

  NCT06215586· 2. fázis· Cardurion Pharmaceuticals, Inc.· Forrás

• Lezárult

  The Perceived Mismatch Between Dose Recommendations of PKI's and the Clinical Practice

  NCT06402812· University Medical Center Groningen· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06212999· 3. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

  NCT06140836· 3. fázis· Bristol-Myers Squibb· Forrás

• Lezárult

  A first-in-human trial of safety and efficacy of GEN3017 in subjects with Hodgkin lymphoma or non-Hodgkin lymphoma

  NCT06018129· 1/2. fázis· Genmab A/S· Forrás

• Lezárult

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

  NCT06066528· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

  NCT06066515· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer

  NCT05724602· 2. fázis· European Organisation For Research And Treatment Of Cancer· Forrás

• Fut, nem toboroz

  Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

  NCT05782907· 3. fázis· AbbVie· Forrás

• Lezárult

  Taste and Smell Dysfunction in Patients More Than Two Years After Start of Immune Checkpoint Inhibitor Therapy

  NCT06495008· University Medical Center Groningen· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Amgen Inc.· Forrás

• Lezárult

  Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)

  NCT06036836· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children

  NCT05818644· University Medical Center Groningen· Forrás

• Lezárult

  A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy

  NCT05958407· 3. fázis· LEO Pharma· Forrás

• Fut, nem toboroz

  Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

  NCT05464381· 3. fázis· RHEACELL GmbH & Co. KG· Forrás

• Lezárult

  A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis Suppurativa

  NCT05849922· 2. fázis· Sanofi· Forrás

• Fut, nem toboroz

  Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer

  NCT05740566· 3. fázis· Amgen· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer

  NCT05450484· 1. fázis· University Medical Center Groningen· Forrás

• Fut, nem toboroz

  A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis

  NCT05785611· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

  NCT05819359· 2. fázis· Bial R&D Investments, S.A.· Forrás

• Lezárult

  Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

  NCT05767034· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

  NCT05742802· 3. fázis· AstraZeneca· Forrás

Showing 50 of 174.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Szívelégtelenség283 munka · 37 vizsgálat
• Krónikus vesebetegség108 munka · 19 vizsgálat
• 2-es típusú cukorbetegség103 munka · 6 vizsgálat
• Tüdőrák90 munka · 68 vizsgálat
• Asztma88 munka · 2 vizsgálat
• Pitvarfibrilláció82 munka · 14 vizsgálat
• Skizofrénia59 munka · 6 vizsgálat
• Krónikus obstruktív tüdőbetegség (COPD)53 munka · 23 vizsgálat
• Prosztatarák51 munka · 19 vizsgálat
• Depresszió41 munka · 8 vizsgálat
• Akut mieloid leukémia (AML)39 munka · 21 vizsgálat
• Fej-nyaki daganatok37 munka · 27 vizsgálat
• Crohn-betegség33 munka · 12 vizsgálat
• Koszorúér-betegség31 munka · 6 vizsgálat
• Colitis ulcerosa29 munka · 6 vizsgálat
• Bipoláris zavar28 munka · 1 vizsgálat
• Amiloidózis27 munka · 17 vizsgálat
• Aortic aneurysm21 munka · 3 vizsgálat
• Congenital heart disease16 munka · 1 vizsgálat
• Aortic stenosis16 munka · 5 vizsgálat
• Giant cell arteritis16 munka · 4 vizsgálat
• Hodgkin-limfóma14 munka · 9 vizsgálat
• IgA-nefropátia13 munka · 4 vizsgálat
• Méhtestrák13 munka · 11 vizsgálat
• Follikuláris limfóma13 munka · 6 vizsgálat
• Dystonia12 munka · 0 vizsgálat
• Polymyalgia rheumatica12 munka · 3 vizsgálat
• Policisztás vesebetegség12 munka · 4 vizsgálat
• Gestational diabetes12 munka · 2 vizsgálat
• Dilated cardiomyopathy11 munka · 2 vizsgálat